TEAM LEADER
Michael Berger, PhD
Co-Director, Kravis Center for Molecular Oncology;
Chief Attending, Clinical Computational Diagnostics Service
Department of Pathology and Laboratory Medicine
Memorial Sloan Kettering Cancer Center
New York, NY
TEAM MEMBERS
Maria E. Arcila, MD
Chaitanya Bandlamudi, PhD
Ryma Benayed, PhD
A. Rose Brannon, PhD
Debyani Chakravarty, PhD
Donavan T. Cheng, PhD
Mark Donoghue, PhD
JianJiong Gao, PhD
David Hyman, MD
Marc Ladanyi, MD
Brian Loomis, PhD
Diana Mandelker, MD, PhD
Khedoudja Nafa, PharmD, PhD
Kenneth Offit, MD, MPH
Mark Robson, MD
Nikolaus Schultz, PhD
David B. Solit, MD
Zsofia K. Stadler, MD
Aijazuddin Syed, MS
Barry S. Taylor, PhD
Ahmet Zehir, PhD
Liying Zhang, MD, PhD
For pivotal advancements in clinical genomic sequencing that have transformed oncology practice, clinical trials, and cancer discovery research. The MSK-IMPACT team developed and implemented a groundbreaking next-generation sequencing platform, thereby enabling the comprehensive molecular characterization of over 125,000 tumors and driving major insights into cancer biology, biomarker-driven therapies, and precision oncology. By integrating MSK-IMPACT into a CLIA-compliant laboratory from inception, the team ensured that each patient directly benefits from their genomic data, facilitating informed decision-making for the most appropriate treatment and/or clinical trial. Their innovative work has set new standards for the integration of genomic data into clinical care, propelled landmark clinical trials, and advanced data-sharing initiatives worldwide.
The AACR Team Science Award recognizes an outstanding interdisciplinary research team for its innovative and meritorious science that has advanced or likely will advance our fundamental knowledge of cancer, or a team that has applied existing knowledge to advance the detection, diagnosis, prevention, or treatment of cancer. To learn more, please visit the press release.
View Past Recipients.